Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
latest_posts
- 1
Google's proposed data center in orbit will face issues with space debris in an already crowded orbit - 2How comfort foods trigger pleasure in our brains
- 337 Things Just Individuals Experiencing childhood during the 80s Will Comprehend
- 4Step by step instructions to Involve Compact disc Rates for Magnanimous Giving
- 5Affordable Care Act enrollment is slightly ahead of last year, despite expiring subsidies
- Some are walking out. Some are shouting. Some are oblivious. How kids are reacting to THAT 'Wicked: For Good' scene
- At least 7 dead as Israel renews attacks on Beirut and across Lebanon
- FDA adds strongest warning to Sarepta gene therapy linked to 2 patient deaths
- Revealing the Incomparable Realms: An Excursion through Power and Inheritance
- France to build new nuclear aircraft carrier, Macron says
- Dominating Capable Mastercard Utilization: Key Contemplations
- Vote In favor of Your Favored Video Conferencing Administration
- Instructions to Distinguish the Wellbeing Dangers Related with 5G Pinnacles
- Extreme Manual for Purchasing Your Next Truck
